Lv3
290 积分 2024-01-17 加入
Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual
3小时前
已完结
Equecabtagene Autoleucel in Patients With Relapsed or Refractory Multiple Myeloma
18小时前
已完结
Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group
2天前
已完结
Minimally invasive, maximally impactful: minimally invasive glaucoma surgery and the changing glaucoma landscape
8天前
已完结
Performance of systemic lupus erythematosus responder index for detecting clinician‐rated responders in patients with active systemic lupus erythematosus
13天前
已完结
Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2, open-label, basket trial
27天前
已完结
CARTIFAN-1: Concerning fatal adverse events with global use of chimeric antigen receptor–T-cell therapy in multiple myeloma
1个月前
已完结
Current understanding and management of CAR T cell-associated toxicities
2个月前
已完结
KarMMa-3: A Phase 3 Study of Idecabtagene Vicleucel (ide-cel, bb2121), a BCMA-Directed CAR T Cell Therapy Vs Standard Regimens in Relapsed and Refractory Multiple Myeloma
2个月前
已关闭
Recovery-model: A model for CAR T-cell-related thrombocytopenia in relapsed/refractory multiple myeloma
2个月前
已完结
Short Culture of Bovine Hepatocytes Biopsied from Dairy Cows as a Model for Toxicological Studies—CYP 1A1 Activity Response to Zearalenone Treatment
10个月前
已采纳
Short Culture of Bovine Hepatocytes Biopsied from Dairy Cows as a Model for Toxicological Studies—CYP 1A1 Activity Response to Zearalenone Treatment
10个月前
已撤回
皖公网安备34019202002308
